Clene Announces New Exploratory Analyses Results

(24/7 MARKET NEWS) – Clene Inc. (NASDAQ: CLNN) reported, this morning, new results from exploratory analyses including delayed time to key clinical progression events in people living with amyotrophic lateral sclerosis (ALS) who were treated with CNM-Au8(R) in the HEALEY ALS Platform Trial over the 6-months of the double-blind period.

Highlights include;

• CNM-Au8 associated with a 74% lower risk (lower hazard ratio) of ALS clinical worsening, which included death, non-invasive ventilation >22 hours per day, tracheostomy, or feeding tube placement (p = 0.035)

• CNM-Au8 associated with a 98% lower risk of death or permanent assisted ventilation (p= 0.028)

• CNM-Au8 associated with a 74% lower risk of feeding tube placement (p= 0.035)

• CNM-Au8 associated with a 63% lower risk of initiation of assisted ventilation (p= 0.058)

• CNM-Au8 treatment was well-tolerated without significant safety concerns

Clene is trading at $1.47, up $0.17 (+13.07%), on 2.2 million premarket shares.

Its 52-week trading range is $0.87 to $5.13. It made a big one day run on February 13.

24/7 MARKET NEWS, INC Disclaimer

24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.

Please go to or for further information.


Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist